A chalazion is a firm eyelid lump from a blocked gland. Learn when it may clear on its own, when surgical drainage is needed, and what recovery in Dubai involves. hygiene. Those that persist beyond four to six weeks, are large, or affect vision are unlikely to resolve without intervention. Surgical drainage — an incision made on the inner surface of the eyelid under local anaesthesia — is the most reliable treatment. The procedure takes 15–20 minutes, leaves no visible external scar, and has a low rate of complications. Most patients notice improvement within days and are fully recovered within two weeks.
A chalazion — pronounced kuh-LAY-zee-on — is one of the most common eyelid conditions I see in my Dubai practice. Patients arrive having tried warm compresses for weeks or months, sometimes having been prescribed antibiotic drops that have made no difference, and often frustrated that something so small has proved so resistant to going away on its own.
This article explains what a chalazion is, why it forms, when conservative treatment is appropriate, and when surgery is the right decision. It is written for patients who want to understand their condition before deciding on a course of action — which is exactly the approach I encourage.
The eyelids contain two rows of specialised glands called meibomian glands — approximately 25–30 in the upper eyelid and 20–25 in the lower. These glands open along the inner edge of the eyelid and secrete the oily component of the tear film, which prevents tears from evaporating too quickly and keeps the ocular surface lubricated.
When the opening of a meibomian gland becomes blocked — by inspissated (thickened) secretion, by chronic inflammation, or by a preceding stye — the gland's contents cannot drain normally. The accumulated secretion triggers a granulomatous inflammatory reaction: the body encapsulates the material, forming a firm, round, usually painless lump within the eyelid tissue. This is a chalazion.
It is important to understand what a chalazion is not: it is not an infection. It does not contain pus in the way that an abscess does. Antibiotics — which are frequently prescribed — have no meaningful effect on a formed chalazion. The treatment is either resolution of the granuloma over time (conservative management) or physical evacuation of the contents (surgical drainage).
Patients frequently confuse chalazia with styes, and the two conditions are related — a stye can precede or trigger a chalazion. Understanding the distinction matters because the treatment differs.
A single chalazion can affect anyone. Patients who experience recurrent chalazia — multiple episodes in the same or different locations — typically have an underlying condition affecting their meibomian glands:
MGD is the most common underlying cause of recurrent chalazia. It is a chronic condition in which the meibomian glands produce abnormally thick, inspissated secretion that blocks easily. The condition is extremely common — estimated to affect 40–60% of the adult population in the Middle East, partly due to the dry climate and air-conditioned environments of the UAE. Patients with MGD benefit from regular warm compress therapy, lid massage, and in some cases oral antibiotics or omega-3 supplementation to improve gland function.
Ocular rosacea — the ophthalmic manifestation of rosacea — causes chronic inflammation of the eyelid margins and meibomian gland dysfunction. Patients with rosacea are significantly more prone to chalazion formation. Management of the underlying rosacea is important in reducing recurrence.
Chronic inflammation of the eyelid margins, often associated with seborrhoeic dermatitis, predisposes to meibomian gland blockage and chalazion formation. Regular lid hygiene — cleaning the eyelid margins with a warm, wet cloth or dedicated lid wipes — is an important part of managing this condition.
Some patients notice that chalazia occur more frequently during periods of hormonal change — for example, during pregnancy or menopause. The mechanism is not fully established but is thought to relate to changes in sebaceous secretion.
The natural history of a chalazion depends on its size, duration, and the patient's underlying gland health. Very small, recent chalazia — particularly those treated promptly with warm compresses within the first week or two — have a reasonable chance of resolving without intervention. The window for conservative treatment is approximately four to six weeks from onset. After this point, the granuloma has typically become well-encapsulated and firm, and the likelihood of spontaneous resolution drops significantly.
The following factors favour spontaneous resolution:
The following factors make spontaneous resolution unlikely:
Warm compresses are the foundation of chalazion management — but they need to be done correctly to be effective. Most patients apply them incorrectly: too cool, too briefly, or without any mechanical element. The purpose of a warm compress is to heat the gland contents sufficiently to liquefy the inspissated secretion and allow it to drain naturally.
Surgical drainage is appropriate when:
Steroid injection — triamcinolone acetonide injected directly into the chalazion — is an intermediate option that can be effective for some chalazia, particularly softer, more recent lesions. It is less reliable than surgical drainage for firm, encapsulated, or large chalazia, and carries a small risk of depigmentation at the injection site — relevant to patients with darker skin tones, which is common in the UAE population. I discuss this option at consultation where appropriate.
Chalazion removal is a minor procedure, but it should be performed by someone with specific eyelid surgical training — both for the quality of the procedure and because the eyelid is adjacent to the eye. The procedure I perform is the standard and most reliable technique: incision and curettage through the inner (conjunctival) surface of the eyelid.
The eyelid is anaesthetised with a small injection of local anaesthetic. This causes a brief stinging sensation. Within a minute, the eyelid is fully numb and the procedure is painless.
The eyelid is everted — turned inside out — and a small clamp is applied to isolate the chalazion and reduce bleeding. The inner (conjunctival) surface of the eyelid is now facing upward.
A small incision is made on the conjunctival surface directly over the chalazion. The contents — a combination of lipid material and granulomatous tissue — are evacuated using a curette. The cavity is cleaned thoroughly to reduce the risk of recurrence.
Because the incision is made on the inner surface of the eyelid, there is no visible external scar and no sutures are required. The conjunctival wound heals rapidly without stitches.
A pad is placed over the eye for one to two hours after surgery to reduce swelling. Antibiotic and steroid eye drops are prescribed for one week. Patients go home the same day and can return to normal activities the following day.
The entire procedure takes approximately 15–20 minutes. Where multiple chalazia are present in the same or both eyelids, they can all be treated in a single session.
Recovery from chalazion drainage is rapid and straightforward for most patients. The following is typical:
Recurrent chalazia are one of the most common concerns patients raise at consultation. A chalazion in the same location that recurs after adequate surgical drainage should raise a specific concern: any eyelid lesion that recurs repeatedly in the same location after proper treatment should be sent for histopathological examination to exclude a rare eyelid tumour, particularly sebaceous cell carcinoma — a malignant tumour that can mimic a chalazion clinically.
This does not mean that every recurrent chalazion is suspicious — the vast majority are not. But the investigation should be done, and it is a clinical responsibility that an experienced eyelid surgeon takes seriously.
For patients with genuinely recurrent chalazia driven by underlying meibomian gland dysfunction, the management of the underlying condition is as important as treating the individual chalazion. I discuss this at consultation and may recommend:
Patients sometimes attempt to squeeze or puncture a chalazion themselves. This is strongly inadvisable. The eyelid is thin, the contents of a chalazion are not in a cavity that opens to the skin surface, and the eye is immediately adjacent. Attempting drainage without proper equipment, anaesthesia, and eyelid eversion does not evacuate the chalazion effectively and risks introducing infection, creating scarring, or injuring the cornea. If a chalazion needs draining, it should be done correctly — by someone trained to do it.
This depends on your insurance policy and the clinical indication. Chalazion removal performed purely for cosmetic reasons is typically not covered. However, if the chalazion is:
…then the procedure may qualify as medically indicated and be partially or fully covered. I provide clinical documentation for insurance pre-authorisation where appropriate. Please bring your insurance card and policy details to your consultation if this is relevant to you.
A chalazion is a firm, usually painless lump in the eyelid caused by a blocked meibomian gland. It is not an infection — it is a chronic granulomatous reaction to accumulated gland secretion. Antibiotics do not resolve a chalazion. Treatment is either conservative (warm compresses and lid hygiene) or surgical (incision and curettage).
Four to six weeks of correctly applied warm compresses is a reasonable trial for small, recent chalazia. If there has been no meaningful reduction in size after this period, or if the chalazion is large, firm, or affecting vision, surgical drainage is the more reliable next step. Continuing warm compresses indefinitely for a chalazion that is not responding wastes time and delays appropriate treatment.
No. The incision is made on the inner (conjunctival) surface of the eyelid, leaving no visible external scar. This is one of the significant advantages of the standard surgical approach over attempts to drain a chalazion through the skin.
Most patients experience bruising and swelling for two to three days, with the majority returning to work and normal activities on day two. The eyelid appears normal within one to two weeks. Antibiotic drops are used for one week post-operatively. Full follow-up is at two to four weeks.
Recurrence at a different site is possible, particularly in patients with underlying meibomian gland dysfunction, rosacea, or blepharitis. These conditions predispose to repeated gland blockage. Addressing the underlying cause reduces but does not eliminate recurrence risk. A chalazion that returns repeatedly in the same location after adequate surgical treatment should be biopsied to exclude a rare eyelid tumour.
Where the chalazion is medically indicated — causing vision impairment or recurrent infection — the procedure may qualify for insurance coverage. Fees and insurance guidance are provided following a consultation and examination. To discuss the procedure, book a consultation using the contact form on this website.
You do not need a referral to see me for a chalazion. If you have a lump in your eyelid that has been present for more than four weeks and is not resolving with warm compresses, or if it is large, affecting your vision, or concerning you in any way, a consultation is the right next step.
At the appointment, I will confirm the diagnosis — ruling out conditions that can mimic a chalazion — assess whether conservative management is still appropriate or whether drainage is indicated, and if surgery is needed, explain exactly what the procedure involves and answer all your questions before you decide anything.
I see patients at Dubai Healthcare City in English, Arabic and German, without referral and without obligation.
Considering eyelid surgery in Dubai? Book a consultation with Dr. Alia Issa.